Chief Scientific Officer and President, Worldwide Research, Development and Medical
Pfizer Inc.
New York, New York, United States
Mikael Dolsten, M.D., Ph.D.
Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.
Mikael leads Worldwide Research, Development and Medical at Pfizer, and is responsible for the development of all compounds through proof of concept, with pharmaceutical sciences, safety, and medical support for the pipeline and all marketed medicines and vaccines.
Mikael earned his Ph.D. in tumor immunology and M.D. from the University of Lund, where he was Adjunct Professor in Tumor Immunology. He serves on the PhRMA R&D Leadership Forum and the PhRMA Foundation Board of Directors. He is a board member at Agilent Technologies, Research! America, and Vimian. Mikael is a member of the Board of Overseers for the Scripps Research Institute, a Foreign Member of The Royal Swedish Academy of Engineering Sciences, and co-chairs the Accelerating Medicine Partnership. He advised the Obama Administration, as well as then Vice President Biden’s Cancer Moonshot Initiative.
Mikael is a named inventor on several patents and has published approximately 150 articles in international journals.
Disclosure information not submitted.
Wednesday, June 22, 2022
8:40 AM – 9:05 AM PT
